Claudio Martín

3.4k total citations
58 papers, 786 citations indexed

About

Claudio Martín is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Claudio Martín has authored 58 papers receiving a total of 786 indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Pulmonary and Respiratory Medicine, 41 papers in Oncology and 6 papers in Molecular Biology. Recurrent topics in Claudio Martín's work include Lung Cancer Treatments and Mutations (39 papers), Lung Cancer Research Studies (24 papers) and Lung Cancer Diagnosis and Treatment (20 papers). Claudio Martín is often cited by papers focused on Lung Cancer Treatments and Mutations (39 papers), Lung Cancer Research Studies (24 papers) and Lung Cancer Diagnosis and Treatment (20 papers). Claudio Martín collaborates with scholars based in Argentina, Mexico and United States. Claudio Martín's co-authors include Óscar Arrieta, Andrés F. Cardona, Luis Corrales, Zyanya Lucía Zatarain-Barrón, R. Rosell, Hernán Carranza, Carlos Vargas, Jorge Otero, Mauricio Cuello and Luís Más and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Annals of Oncology.

In The Last Decade

Claudio Martín

49 papers receiving 778 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Claudio Martín Argentina 13 466 461 207 152 105 58 786
Melissa A. Reimers United States 13 532 1.1× 461 1.0× 284 1.4× 252 1.7× 158 1.5× 53 921
Nuria Romero-Laorden Spain 14 275 0.6× 491 1.1× 163 0.8× 223 1.5× 91 0.9× 60 779
Deanna McLeod Canada 15 229 0.5× 461 1.0× 222 1.1× 224 1.5× 49 0.5× 26 793
William Berry United States 8 252 0.5× 226 0.5× 297 1.4× 164 1.1× 55 0.5× 16 675
M. Puglisi Italy 16 408 0.9× 539 1.2× 257 1.2× 68 0.4× 90 0.9× 38 998
Christopher W. Lee Canada 14 448 1.0× 520 1.1× 326 1.6× 82 0.5× 70 0.7× 24 980
Milena Perez Mak Brazil 12 234 0.5× 399 0.9× 189 0.9× 137 0.9× 108 1.0× 34 664
Capucine Baldini France 16 280 0.6× 686 1.5× 140 0.7× 103 0.7× 172 1.6× 89 964
Shugeng Gao China 18 523 1.1× 486 1.1× 272 1.3× 207 1.4× 109 1.0× 53 1.0k
Arnd Nusch Germany 14 476 1.0× 437 0.9× 126 0.6× 215 1.4× 33 0.3× 50 729

Countries citing papers authored by Claudio Martín

Since Specialization
Citations

This map shows the geographic impact of Claudio Martín's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claudio Martín with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claudio Martín more than expected).

Fields of papers citing papers by Claudio Martín

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claudio Martín. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claudio Martín. The network helps show where Claudio Martín may publish in the future.

Co-authorship network of co-authors of Claudio Martín

This figure shows the co-authorship network connecting the top 25 collaborators of Claudio Martín. A scholar is included among the top collaborators of Claudio Martín based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claudio Martín. Claudio Martín is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
López-Correa, Catalina, et al.. (2025). Precision Medicine for Cancer and Health Equity in Latin America: Generating Understanding for Policy and Health System Shaping. International Journal of Environmental Research and Public Health. 22(8). 1220–1220.
2.
3.
Pérol, M., Benjamin Solomon, Kōichi Goto, et al.. (2024). CNS Protective Effect of Selpercatinib in First-Line RET Fusion-Positive Advanced Non–Small Cell Lung Cancer. Journal of Clinical Oncology. 42(21). 2500–2505. 5 indexed citations
4.
Lara‐Mejía, Luis, Andrés F. Cardona, Luís Más, et al.. (2023). Impact of Concurrent Genomic Alterations on Clinical Outcomes in Patients With ALK-Rearranged NSCLC. Journal of Thoracic Oncology. 19(1). 119–129. 11 indexed citations
5.
Arrieta, Óscar, Luis Lara‐Mejía, Jenny G. Turcott, et al.. (2023). Perilesional edema diameter associated with brain metastases as a predictive factor of response to radiotherapy in non-small cell lung cancer. Frontiers in Oncology. 13. 1251620–1251620. 2 indexed citations
6.
Arrieta, Óscar, Andrés F. Cardona, Vladmir Cláudio Cordeiro de Lima, et al.. (2023). P2.10-13 Characteristics and Outcomes of Hispanic Patients with RET-Fusion Positive NSCLC Treated in Real-World Practice. Journal of Thoracic Oncology. 18(11). S357–S358.
7.
Avilés‐Salas, Alejandro, Norma Hernández‐Pedro, Suraj Samtani, et al.. (2023). PD-L1 expression complements CALGB prognostic scoring system in malignant pleural mesothelioma. Frontiers in Oncology. 13. 1269029–1269029. 3 indexed citations
8.
López, Carlos, et al.. (2022). Assessing the methodological quality of quality-of-life analyses in first-line non-small cell lung cancer trials: A systematic review. Critical Reviews in Oncology/Hematology. 176. 103747–103747. 6 indexed citations
9.
Ahn, Myung‐Ju, Fabrice Barlési, Enriqueta Felip, et al.. (2021). MO01.29 Randomized, Open-Label Study of Bintrafusp Alfa vs. Pembrolizumab as First-Line (1L) Treatment in Patients with PD-L1–Expressing Advanced Non-Small Cell Lung Cancer (NSCLC). Journal of Thoracic Oncology. 16(1). S27–S28. 3 indexed citations
10.
Ángel, Martín, Renata Colombo Bonadio, Guilherme Harada, et al.. (2020). Mentoring as an opportunity to improve research and cancer care in Latin America (AAZPIRE project). ESMO Open. 5(6). e000988–e000988. 7 indexed citations
11.
Wu, Yi‐Long, Byoung Chul Cho, Qing Zhou, et al.. (2018). MA02.03 ASTRIS: A Real World Treatment Study of Osimertinib in Patients with EGFR T790M-Positive NSCLC. Journal of Thoracic Oncology. 13(10). S358–S359. 1 indexed citations
12.
Batagelj, Emilio, et al.. (2018). Analysis of EML4-ALK rearrangement in non-small cell lung cancer in Argentina. Annals of Diagnostic Pathology. 34. 77–81. 5 indexed citations
13.
Corrales, Luis, Óscar Arrieta, Luís Más, et al.. (2017). An international epidemiological analysis of young patients with non-small cell lung cancer (AduJov-CLICaP). Lung Cancer. 113. 30–36. 25 indexed citations
14.
Mok, Tony, Peter Schmid, Gilberto de Castro, et al.. (2017). P2.06-022 First-Line Durvalumab plus Tremelimumab vs Platinum-Based Chemotherapy for Advanced/Metastatic NSCLC: Phase 3 NEPTUNE Study. Journal of Thoracic Oncology. 12(1). S1084–S1084. 5 indexed citations
15.
Cardona, Andrés F., Óscar Arrieta, Leonardo Rojas, et al.. (2016). O.01: Acquired Resistance to EGFR-TKIs in EGFR-Mutant Lung Adenocarcinoma Among Hispanics (RBIOP-CLICaP). Journal of Thoracic Oncology. 11(10). S168–S168. 1 indexed citations
16.
Rojas, Leonardo, Andrés F. Cardona, Óscar Arrieta, et al.. (2016). PD2.04 (also presented as P1.42): PEM/CBP/BEV Followed by Maintenance PEM/BEV in Hispanic Patients With NSCLC: Outcomes According to TS, ERCC1 and VEGF. Journal of Thoracic Oncology. 11(10). S177–S178. 1 indexed citations
17.
Rojas, Leonardo, Andrés F. Cardona, Óscar Arrieta, et al.. (2016). P1.42 (also presented as PD2.04): PEM/CBP/BEV Followed by Maintenance PEM/BEV in Hispanic Patients With NSCLC: Outcomes According to TS, ERCC1 and VEGF. Journal of Thoracic Oncology. 11(10). S208–S209. 1 indexed citations
18.
19.
Arrieta, Óscar, Gonzalo Recondo, Diego Kaen, et al.. (2015). Real-World Patient Characteristics, Treatment Patterns, and Survival among Locally-Advanced/Metastatic Alk+ Non-Small Cell Lung Cancer Patients in Latin America. Value in Health. 18(7). A817–A817. 1 indexed citations
20.
Arrieta, Óscar, Andrés F. Cardona, Claudio Martín, et al.. (2015). Updated Frequency of EGFR and KRAS Mutations in NonSmall-Cell Lung Cancer in Latin America: The Latin-American Consortium for the Investigation of Lung Cancer (CLICaP). Journal of Thoracic Oncology. 10(5). 838–843. 143 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Melissa A. Reimers Breakdown of academic impact, for papers by Nuria Romero-Laorden Breakdown of academic impact, for papers by Deanna McLeod Breakdown of academic impact, for papers by William Berry Breakdown of academic impact, for papers by M. Puglisi Breakdown of academic impact, for papers by Christopher W. Lee Breakdown of academic impact, for papers by Milena Perez Mak Breakdown of academic impact, for papers by Capucine Baldini Breakdown of academic impact, for papers by Shugeng Gao Breakdown of academic impact, for papers by Arnd Nusch
Rankless by CCL
2026